Physician profile
Grant R Simons
NPI 1568532927
$93,485.36
in general payments reported to CMS, 2019-2025
30 companies · $44K in 2025
The $44K reported for 2025 was more than what 94% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $3,964 · 2021: $831 · 2022: $3,715 · 2023: $979 · 2024: $29K · 2025: $44K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $55K · Travel and Lodging: $9,442 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,250 · Food and Beverage: $4,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $54,917.50 |
| Travel and Lodging | $9,442.02 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,250.00 |
| Food and Beverage | $4,097.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $37,908.83 | 2019-2025 | |
| Abbott Laboratories | $35,922.50 | 2019-2025 | Amplatzer Amulet, Aveir, Mitraclip |
| E.R. Squibb & Sons, L.L.C. | $8,088.73 | 2019-2025 | Camzyos |
| Boston Scientific Corporation | $5,202.52 | 2019-2025 | Watchman Flx, Watchman, General - Therapies |
| Medtronic Vascular, INC. | $2,687.88 | 2019-2020 | |
| Medtronic, INC. | $1,806.89 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Micra, Cobalt Dr Mri Surescan |
| Abiomed | $395.03 | 2023-2025 | Impella |
| Atricure, INC. | $232.39 | 2020-2024 | |
| W. L. Gore & Associates, INC. | $189.35 | 2022-2023 | Gore Cardioform Septal Occluder |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $183.72 | 2019-2024 | Lifevest |
| Amgen INC. | $130.89 | 2019-2025 | Repatha |
| Biosense Webster, INC. | $119.28 | 2019-2022 | |
| Penumbra, INC. | $99.50 | 2023 | Indigo System |
| Cordis US Corp. | $98.08 | 2025 | Mynx Control Venous |
| Astrazeneca Pharmaceuticals Lp | $73.46 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $57.28 | 2022-2024 | Savvywire |
| Biotronik INC. | $36.23 | 2020 | |
| Irhythm Technologies, INC. | $35.24 | 2023 | Zio Xt Patch |
| Pfizer INC. | $28.60 | 2019-2020 | |
| Philips North America LLC | $26.81 | 2025 | Mcot |
| Regeneron Healthcare Solutions, INC. | $22.74 | 2019 | |
| Kestra Medical Technology Services, INC. | $18.99 | 2025 | Assure Wcd |
| Ge Healthcare | $18.79 | 2022 | |
| Ethicon US, LLC | $17.76 | 2025 | Surgiflo Hemostatic Matrix, Ethicon |
| Impulse Dynamics (USA) INC. | $17.00 | 2021 | |
| Alnylam Pharmaceuticals INC. | $16.86 | 2025 | Amvuttra |
| Janssen Pharmaceuticals, INC | $13.41 | 2020 | |
| Lundbeck LLC | $13.33 | 2020 | |
| Amarin Pharma, INC. | $12.28 | 2019 | |
| Preventice Services, LLC | $10.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Simons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.